Talis Biomedical slumps as CEO steps down
31/08/2021 15:03
** Shares of Talis Biomedical Corp TLIS.O down as much as
10.7% to $8.04
** Co says CEO Brian Coe has stepped down from his role,
effective immediately urn:newsml:reuters.com:*:nGNX882VKv
** Co names Kim Popovits as interim CEO, who will lead the
search to hire co's next CEO
** Popovits is the former CEO of biotech firm Genomic Health
** BofA Global Research cuts price objective on Talis stock
to $10 from $11
(Reporting by Rithika Krishna in Bengaluru)
((Rithika.Krishna@thomsonreuters.com;))
Recent news on Talis Biomedical
See all newsBrief: Talis Biomedical Says Nasdaq Believes Co Is 'Public Shell' And Continued Listing Of Its Common Stock Is No Longer Warranted
Brief: Talis Biomedical Says Accepting Voluntary Resignation Of Heinrich Dreismann From Board Effective August 1
Brief: Talis Biomedical Eliminates Andrew Lukowiak As President And Chief Scientific Officer
Talis Biomedical up on plans to explore strategic options, job cuts
Brief: Talis Biomedical Announces Exploration Of Strategic Alternatives And Cost Reduction Plan To Preserve Cash